🇺🇸 FDA
Patent

US 10183080

Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos

granted A61KA61K31/704A61K38/08

Quick answer

US patent 10183080 (Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos) held by The Government of the United States of America, as represented by the Secretary of the Navy expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America, as represented by the Secretary of the Navy
Grant date
Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/704, A61K38/08, A61K47/52, A61K47/62